Livtencity

Active Ingredient(s): Maribavir
FDA Approved: * November 23, 2021
Pharm Company: * TAKEDA PHARMS USA
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Livtencity Overview

Maribavir, sold under the brand name Livtencity, is an antiviral medication that is used to treat post-transplant cytomegalovirus (CMV).[1][2] The most common side effects include taste disturbance, nausea, diarrhea, vomiting and fatigue.[2] Maribavir is a cytomegalovirus pUL97 kinase inhibitor that works by preventing the activity of human cytomegalovirus enzyme pUL97, thus blocking virus replication.[2] Maribavir was approved f...

Read more Livtencity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Maribavir

Recent Livtencity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Maribavir
  • Tablet: 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Maribavir or a similar ingredient: (1 result)